China Vaccine Industry Report, 2008-2009
  • Aug/2009
  • Hard Copy
  • USD $1,450
  • Pages:77
  • Single User License
    (PDF Unprintable)       
  • USD $1,500
  • Code: ZX006
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $2,200
  • Hard Copy + Single User License
  • USD $1,650
      

In the past decade, Chinese vaccine market tripled in scale. China has already become the world’s largest vaccine producer and now has 28 vaccine companies, ranking NO.1 around the globe. It can produce one billion person-portions annually, besides, varieties and quantity also ranks the top in the world.

Output of common vaccine reaches 500 million person-portions such as HBV vaccine, measles vaccine, etc. Fully planned immunization has been realized.

Expenses on Vaccines Proportion to Treatment Cost in China and Developed Countries
2009080502.gif
Source: ResearchInChina

Compared to developed countries, expenses of China on vaccine and diseases treatment are relatively low; therefore, China will attach great importance to vaccine industry development and take it as the key of healthcare and bio-technology industry. The Development Strategy of China Bio-technology Industry has rendered the development of secure new types of vaccines as priority; in the meantime, Chinese government has employed preferential taxation policy to this industry. In consequence, vaccine industry will become a high-tech sector with great potential in China bio-technology field. It is forecasted that China vaccine market scale will approximate RMB8 billion in 2020, with an annual growth rate of 15%, far above world’s level 10%.

Based on authoritative statistics, this report makes in-depth analysis on China vaccine industry development, vaccine market, vaccine import & export, key vaccine producers, and also forecasts the development trend of China's vaccine industry in 2009. Vaccines involved in this report are Flu Vaccine, HBV Vaccine, Cerebrospinal Meningitis Vaccine, HIV vaccine, A/HINI vaccine as well as animal vaccines.

1. Overview of China Vaccine Market
1.1 Impact of Globalization on China Pharmaceutical Market
1.1.1 Pharmaceutical Industry Restructuring and International Division of Labor
1.1.2 Accelerated Globalization of Pharmaceutical Market 
1.1.3 International Status of China Pharmaceutical Industry
1.1.4 Forecast of China Status in Global Pharmaceutical Industry, 2009
1.2 Strategies for the Access into China Vaccine Market
1.2.1 Policy on Foreign Capital Entry into China Vaccine Market 
1.2.2 Competition Strategies of Chinese Vaccine Companies
1.2.3 China Vaccine Market Position in the Global Market
1.3 China Biopharmaceutical Sector
1.3.1 Sales Revenue, 2008
1.3.2 Total production Value, 2008
1.3.3 Development Trend, 2009

2. China Vaccine Market Development in 2008-2009
2.1 Market Characteristics, 2008 
2.2 Main Vaccines Types, 2008
2.3 Market Structure, 2008
2.4 Market Characteristics, 2008
2.5 Market Tendency, 2008
2.6 Suggestions for Vaccine Industry Development, 2008

3. Markets of Vaccine Varieties, 2008
3.1 China Flu Vaccine Market, 2008
3.1.1 Market Background
3.1.2 Technology R&D
3.1.3 Market Size 
3.1.4 Competition 
3.1.5 Market Demand
3.1.6 Key Producers  
3.2 China HBV Vaccine Market
3.2.1 Market Background 
3.2.2 Market Size
3.2.3 Main Products
3.3 China MCV Vaccine Market
3.3.1 Market Background
3.3.2 Market Size 
3.4 China AIDS Vaccine Market 
3.4.1 Market Background
3.4.2 Market Size
3.4.3 R & D
3.5 Other Vaccine Markets and R & D
3.5.1 Lung Cancer Vaccine 
3.5.2 Measles Vaccine 
3.5.3 Cervical Cancer Vaccine 
3.5.4 Lupus Erythematosus Vaccine
3.5.5 Rotavirus Vaccine 
3.5.6 Tumor Vaccine 
3.5.7 A H1N1 Vaccine

4. China Animal Vaccine Market, 2008
4.1 Basis of Demand 
4.1.1 Green Barriers: Promotion of Animal Vaccine 
4.1.2 Market Background of and Demand for Pet Vaccine 
4.2 Research Progress in Vaccine for Animal 
4.2.1 R&D of Animal Virus Vaccine 
4.2.2 Animal Vaccine R&D Bases in China 
4.2.3 Successful Development of Purified Rabies Vaccine for Human 
4.2.4  Research Progress in Pseudorabies Gene-deleted Vaccine
4.3 China Bird Flue Vaccine Market
4.3.1 Market Background 
4.3.2 Key Producers
4.4 Competition Layout of China Animal Vaccine Market

5. Import and Export of China Vaccine 
5.1 General Trend of Vaccine Trade
5.2 Comparison between Imported Vaccine and Homemade Vaccine

6.  China Key Vaccine Producers
6.1 China National Biotech Group Co., Ltd
6.2  Beijing Tiantan Biological Products Co., Ltd
6.3  Shanghai Institute of Biological Products
6.4  Shenzhen Kangtai Biological Products Co., Ltd
6.5 Changchun Changsheng Life Sciences Co., Ltd
6.6 Shenzhen Neptunus Bioengineering Co., Ltd
6.7 Guangxi Beisheng Pharmaceutical Co., Ltd
6.8 Star Lake Bioscience Co., Ltd
6.9 Shanghai Fosun Pharmaceutical (Group) Co., Ltd
6.10 Jiangsu Sihuan Bioengineering Co., Ltd
6.11 Northeast Pharmaceutical Group Co., Ltd
6.12 Chengdu Hoist Group Co., Ltd
6.13 Hualan Biological Engineering Inc.
6.14 China Animal Husbandry Group
6.15 Zhejiang Huahai Pharmaceutical Co., Ltd

7. Impact of SARS on Vaccine Market
7.1 Vaccine Market Activated by SARS
7.1.1 Booming of Vaccine Industry
7.1.2 Bottleneck of Vaccine Industry
7.1.3 R&D of SARS Vaccine 
7.2 Dispute of SARS Patent and Market
7.3 Patent Protection Measures on Anti SARS Vaccine

8. Vaccine Market Development Trend and Forecast, 2009
8.1 Latest Information on Vaccine R&D
8.1.1 Development Trend of New Types of Vaccines 
8.1.2 New Types of Vaccines
8.1.3 R&D of New Types of Vaccines 
8.1.4 New Types of Combined Vaccines
8.2 Forecast of Vaccine Market, 2009
8.2.1 Forecast of Global Various Vaccines Markets, 2009
8.2.2 Forecast of Animal Vaccine Sector
Expenses on Vaccines Proportion to Treatment Cost in China and Developed Countries 
Sales Value of China Pharmaceutical Industry, Jan-Nov 2008
Output Value of China Pharmaceutical Industry, Jan-Nov 2008
China Influenza Virus Vaccine Market Scale, 2007
Virus Vaccine-Split Influenza Virus Vaccine's Dosage Form, Price & Origin, 2008
China HB Vaccine Market Scale, 2007
Virus Vaccine-Recombinant Vaccine of HB's (CHO cell)Dosage Form, Price & Origin, 2008
Virus Vaccine-Recombinant Vaccine of HB's (Barm) Dosage Form, Price & Origin, 2008
Dosage Form, Price & Origin of Measles Vaccine, 2008
Dosage Form, Price & Origin of Measles - mumps combined vaccine, 2008
China Animal Vaccine Market Scale, 2008
China Animal Vaccine Market Scale, 2005-2009
Dosage Form, Price & Origin of Oral Rotavirus Vaccine, 2008
Dosage Form, Price & Origin of Encephalitis B Vaccine, 2008
Dosage Form, Price & Origin of Rubella Vaccine, 2008
Dosage Form, Price & Origin of Parotitis Vaccine, 2008
Dosage Form, Price & Origin of Chickenpox Vaccine, 2008
Dosage Form, Price & Origin of Freeze-dried Hepatitis A Vaccine, 2008
Dosage Form, Price & Origin of Renal Hemorrhagic Fever Vaccine, 2008
Dosage Form, Price & Origin of Rabies Vaccine for Human Being, 2008
Bird Flu Vaccine Production Capacity of CNADC and Jinyu Baoling Bio-pharmaceutical Co.
Key Vaccines Sales of CNADC and Jinyu Baoling Bio-pharmaceutical Co., 2007
Vaccines Sales of CNADC and Jinyu Baoling Bio-pharmaceutical Co., 2008
Anti-serum and Vaccine Import Value, 2007 vs. 2008
Anti-serum and Vaccine Import Value Trend, 2008
Anti-serum and Vaccine Export Value Trend, 2008
Anti-serum and Vaccine Import Volume, 2007-2008
Anti-serum and Vaccine Import Volume Trend, 2008
Anti-serum and Vaccine Export Volume Trend, 2008
Anti-serum and Vaccine Export Value, 2007 vs. 2008
Anti-serum and Vaccine Export Volume, 2007 vs. 2008
Anti-serum and Vaccine Import Value Trend, 2008-2009
Anti-serum and Vaccine Import Volume Trend, 2008-2009
Anti-serum and Vaccine Export Value Trend, 2008-2009
Anti-serum and Vaccine Export Volume Trend, 2008-2009
Profitability of Beijing Tiantan Biological Products Co., 2007-2008
Operation Ability of Beijing Tiantan Biological Products Co., 2007-2008
Debt-paying Ability of Beijing Tiantan Biological Products Co., 2007-2008
Capital Structure of Beijing Tiantan Biological Products Co., 2007-2008
Development Ability of Beijing Tiantan Biological Products Co., 2007-2008
Cash Flow of Beijing Tiantan Biological Products Co., 2007-2008
Main Businesses of Beijing Tiantan Biological Products Co. by Sector and by Product
Main Businesses of Beijing Tiantan Biological Products Co. by Region
Structure of Research Institute of Changchun Changsheng Life Sciences Co.
Profitability of Shenzhen Neptunus Bioengineering Co., 2007-2008
Operation Ability of Shenzhen Neptunus Bioengineering Co., 2007-2008
Debt-paying Ability of Shenzhen Neptunus Bioengineering Co., 2007-2008
Capital Structure of Shenzhen Neptunus Bioengineering Co., 2007-2008
Development Ability of Shenzhen Neptunus Bioengineering Co., 2007-2008
Cash Flow of Shenzhen Neptunus Bioengineering Co., 2007-2008
Main Businesses of Shenzhen Neptunus Bioengineering Co. by Sector and by Product
Main Businesses of Shenzhen Neptunus Bioengineering Co. by Region
Profitability of Guangxi Beisheng Pharmaceutical Co., 2007-2008
Operation Ability of Guangxi Beisheng Pharmaceutical Co., 2007-2008
Debt-paying Ability of Guangxi Beisheng Pharmaceutical Co., 2007-2008
Capital Structure of Guangxi Beisheng Pharmaceutical Co., 2007-2008
Development Ability of Guangxi Beisheng Pharmaceutical Co., 2007-2008
Cash Flow of Guangxi Beisheng Pharmaceutical Co., 2007-2008
Main Businesses of Guangxi Beisheng Pharmaceutical Co. by Sector and by Product
Main Businesses of Guangxi Beisheng Pharmaceutical Co. by Region
Profitability of Star Lake Bioscience Co., 2007-2008
Operation Ability of Star Lake Bioscience Co., 2007-2008
Debt-paying Ability of Star Lake Bioscience Co., 2007-2008
Capital Structure of Star Lake Bioscience Co., 2007-2008
Development Ability of Star Lake Bioscience Co., 2007-2008
Cash Flow of Star Lake Bioscience Co., 2007-2008
Main Businesses of Star Lake Bioscience Co. by Sector and by Product
Main Businesses of Star Lake Bioscience Co. by Region
Pharmaceuticals under Research of Shanghai Fosun Pharmaceutical (Group) Co., 2008 
Profitability of Shanghai Fosun Pharmaceutical (Group) Co., 2007-2008
Operation Ability of Shanghai Fosun Pharmaceutical (Group) Co., 2007-2008
Debt-paying Ability of Shanghai Fosun Pharmaceutical (Group) Co., 2007-2008
Capital Structure of Shanghai Fosun Pharmaceutical (Group) Co., 2007-2008
Development Ability of Shanghai Fosun Pharmaceutical (Group) Co., 2007-2008
Cash Flow of Shanghai Fosun Pharmaceutical (Group) Co., 2007-2008
Main Businesses of Shanghai Fosun Pharmaceutical (Group) Co. by Region
Main Businesses of Shanghai Fosun Pharmaceutical (Group) Co. by Sector 
Main Businesses of Northeast Pharmaceutical Group Co. by Sector in 2008
Operations of Vaccine and Pharmaceutical Business of Chengdu Hoist Group Co., 2008
Main Financial Results of Hualan Biological Engineering Inc., 2008
Main Business Revenue and Profit Structure of CNADC, 2008
Sales Statistics of Key Products of CNADC, 2005-2011E
Sales Statistics of Zhejiang Huahai Pharmaceutical Co., 2006-2008
Classification of Gene Recombination Vaccines 
Immunoglobulin Vector Vaccine
Top Three Infectious Diseases in the World and Death Toll
Vaccines for Respiratory Diseases
Vaccines for Digestive Diseases
Vaccines for Insect-borne Infectious Diseases
Existing Combined Vaccines and Combined Vaccines Under Development 
Pneumococcal Vaccine Market Scale, 2009E
Hepatitis Vaccines Market Scale, 2009E
Pediatric Vaccines Market Scale, 2009E
Adult Vaccines and Influenza Vaccine Market Scale, 2009E
Therapeutic Vaccines Market Scale, 2009E

China Vitamin Industry Report,2014-2017

China is the world's largest production base of vitamins, with vitamin C and vitamin E as its most important products, wherein vitamin C and related products account for more than 60% of its total out...

China Chemical Pharmaceutical Industry Report, 2013-2016

Chemical pharmaceutical consists mainly of chemical drug preparation and active pharmaceutical ingredient (API), and the gross margin of chemical drug preparation industry is generally higher than tha...

China Pharmaceutical Distribution Industry Report, 2013

Thanks to the continuous advancement in new medical reform, China’s pharmaceutical distribution industry has maintained a fairly rapid growth in recent years, with the sales value showed a CAGR of rou...

China Pharmaceutical Glass Packaging Industry Report, 2013-2016

Influenced by the substitution of plastic, aluminum foil and other new packaging materials as well as the declining packaging material purchase prices incurred by the medical reform, China pharmaceuti...

China Chinese Patent Medicine Industry Report, 2013-2016

Chinese patent medicine refers to the certain dosage forms of medicine, under the guidance of TCM (traditional Chinese medicine) theory, made from traditional Chinese medicinal materials in accordance...

Global and China Monoclonal Antibody Industry Report, 2013-2017

Currently, monoclonal antibody agents have been successfully used in the treatment of tumors, cancers and other serious diseases as a heavyweight in the biopharmaceutical industry. In 2009-2012, the m...

Global and China Insulin Industry Report, 2013-2017

As the third largest human health disease following neoplastic disease, cardiovascular and cerebrovascular diseases, the number of diabetic patients has continued growing from 246 million in 2007 to 3...

China Large Volume Parenteral (LVP) Industry Report, 2013-2015

Under the context of China's medical reform and sustainable development of the pharmaceutical market, the output and demand of Large Volume Parenteral (LVP) which is one of the top five Chinese prepar...

China Independent Clinical Laboratory Industry Report,2013-2015

Restricted by the health care system and the medical inspection level (Chinese firms mainly lag behind foreign counterparts in molecular diagnostics and other special tests), Chinese independent clini...

China Vitamin Industry Report, 2012-2015

As a great power of vitamin production and export, China has long been known as the world’s vitamin production base. In recent years, its vitamin exports on external demand accounted for about 80% of ...

China Pharmaceutical Equipment Industry Report, 2012-2015

Driven by the new GMP certification as well as the brisk downstream demand, China pharmaceutical equipment industry has seen steady progress in sales volume and technological content of products over ...

China Genetic Engineering Drug Industry Report, 2011-2012

China gets a late start in developing genetic engineering drug industry, but has achieved leapfrog advance. At present, China has at least one hundred enterprises involved in genetic engineering drugs...

China Animal Vaccine Industry Report, 2011-2012

Along with the frequent outbreaks of animal epidemics, the government’s increasing investment in epidemic prevention and the implementation of compulsory immunization system, Chinese animal vaccine ma...

China Human Vaccine Industry Report, 2011-2012

After decades of development, China has become one of the major producer and consumers of human vaccine around the world. In 2011, human vaccine manufacturers numbered 38 in China and the lot release ...

China Chemical Pharmaceutical Industry Report, 2011

In Jan.-Aug., 2011, the gross industrial output value of Chinese chemical pharmaceutical industry surged by 24.54% YoY to RMB460.531 billion, up 2.67 percentage points over the same period of last yea...

China Pharmaceutical Equipment Industry Report, 2011-2012

In recent years, Chinese pharmaceutical equipment industry has witnessed significant growth in both product quality and technological content, as well as steady rise of sales volume. According to Chin...

China Animal Vaccine Industry Report, 2010-2011

China animal vaccine industry has been fast-growing. The market maintained an average annual growth rate up to 13.6% in 2006-2010, and reached around RMB 7.5 billion in 2010, up 21.0% YoY. With the in...

China Human Vaccine Industry Report, 2010-2011

With the improvement of economy and people’s disease prevention awareness, China’s human vaccine market has expanded in recent years, growing at a CAGR of 24.0% in 2007-2010. In particular, the market...

2005-2014 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号
在线客服系统